Brief: MaxCyte Announces Planned CFO Transition In 2026
12/11/2025 21:08
Nov 12 (Reuters) - MaxCyte Inc MXCT.O: MAXCYTE ANNOUNCES PLANNED CFO TRANSITION IN 2026 MAXCYTE INC - CFO DOUGLAS SWIRSKY TO TRANSITION FROM ROLE IN 2026 MAXCYTE INC - SWIRSKY TO REMAIN CFO UNTIL SUCCESSOR APPOINTED Source text: ID:nGNXbg2ZjJ Further company coverage: MXCT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsCell-engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
Brief: MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
MaxCyte Inc reports results for the quarter ended June 30 - Earnings Summary
MaxCyte Q2 revenue beats estimates
MaxCyte Inc expected to post a loss of 9 cents a share - Earnings Preview